How to check the XIRR of Mirae Asset Healthcare Fund Regular IDCW?

You can track the exact XIRR and portfolio overlapping of Mirae Asset Healthcare Fund Regular IDCW alongside your PMS and AIF investments using the MutualSaathi Portfolio Analyzer.

How to check portfolio overlap for Mirae Asset Healthcare Fund Regular IDCW?

Use the MutualSaathi Portfolio Analyzer to compare Mirae Asset Healthcare Fund Regular IDCW with other funds, PMS, and AIFs to detect hidden stock overlaps.

Mirae Asset Healthcare Fund Regular IDCW

Mirae Asset Mutual Fund

Expense Ratio: 1.93

Risk: Very High

Equity Scheme - Sectoral/ Thematic

Plan: Regular

Benchmark: BSE Healthcare TRI

Inception: 11-06-2018

Exit Load: Nil

Fund Size:₹2,791.33 Cr

Performance

Fund3.99%

Cat. Avg.N/A

Fund4.87%

Cat. Avg.N/A

Fund13.62%

Cat. Avg.N/A

Fund2.62%

Cat. Avg.N/A

10Y

FundN/A

Cat. Avg.N/A

Fund12.74%

Cat. Avg.N/A

Fund Facts

Beta

0.97

Std Dev

16.45%

Taxation

Within 1 Year (STCG (Short Term)):20%

After 1 Year (LTCG (Long Term)):12.5%

*Tax rates as per Finance Act 2024. Surcharge & cess may apply.

Allocation

Visualizing Fund's Exposure

Asset Class

Tap to expand

Market Cap

Tap to expand

Top Sectors

Tap to expand

Asset Class

Market Cap

Top Sectors

Portfolio Holdings

Detailed breakdown of instruments.

	Instrument	Type	Sub-Cat	Cap	Sector	Val (Cr)	% Assets
1	Sun Pharmaceutical Industries Ltd.	Equity	Listed	Large Cap	Pharmaceuticals & Biotechnology	335.85	12.20%
2	Divi's Laboratories Ltd.	Equity	Listed	Large Cap	Pharmaceuticals & Biotechnology	218.36	7.93%
3	Glenmark Pharmaceuticals Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	191.19	6.94%
4	JB Chemicals & Pharmaceuticals Ltd.	Equity	Listed	Small Cap	Pharmaceuticals & Biotechnology	189.57	6.88%
5	Apollo Hospitals Enterprise Ltd.	Equity	Listed	Large Cap	Healthcare Services	169.37	6.15%
6	Lupin Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	139.45	5.06%
7	Aurobindo Pharma Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	119.00	4.32%
8	Dr. Reddy's Laboratories Ltd.	Equity	Listed	Large Cap	Pharmaceuticals & Biotechnology	118.77	4.31%
9	Fortis Healthcare Ltd.	Equity	Listed	Mid Cap	Healthcare Services	102.80	3.73%
10	Laurus Labs Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	98.05	3.56%

Similar Funds

UTI NIFTY 50 ETF

UTI Mutual Fund

Expense Ratio: 0.05

NAV / Fund Size

₹268.44₹70,251.14 Cr

Incep: 24-08-2015

Other ETFsVery High RiskOther

-1.86%

0.54%

-49.93%

-30.34%

-9.25%

Fund Details

UTI NIFTY 50 ETF

NAV / Fund Size₹268.44₹70,251.14 Cr

Other ETFsVery High RiskOther

-1.86%

0.54%

-49.93%

-30.34%

-9.25%

Tata Small Cap Fund-Regular Plan-Growth

TATA Mutual Fund

Expense Ratio: 1.68

NAV / Fund Size

₹38.56₹11,355.70 Cr

Incep: 19-10-2018

Small Cap FundVery High RiskEquity

-8.12%

-0.68%

11.85%

14.40%

19.17%

Fund Details

Tata Small Cap Fund-Regular Plan-Growth

NAV / Fund Size₹38.56₹11,355.70 Cr

Small Cap FundVery High RiskEquity

-8.12%

-0.68%

11.85%

14.40%

19.17%

Mirae Asset NYSE FANG + ETF Fund Of Fund Regular Growth

Mirae Asset Mutual Fund

Expense Ratio: 0.45

NAV / Fund Size

₹41.66₹2,278.90 Cr

Incep: 19-04-2021

FoF DomesticVery High RiskOther

31.58%

40.42%

44.60%

29.16%

31.56%

Fund Details

Mirae Asset NYSE FANG + ETF Fund Of Fund Regular Growth

NAV / Fund Size₹41.66₹2,278.90 Cr

FoF DomesticVery High RiskOther

31.58%

40.42%

44.60%

29.16%

31.56%

SIP Returns

Amount (₹)

Date

7th

Period	SIP Date	Inv(₹)	Val(₹)	Abs(%)	XIRR
1Y	07 Aug, 25	60000	65585	+9.3%	+20.1%
2Y	07 Aug, 24	1.20 L.	1.28 L.	+7.0%	+7.1%
3Y	07 Aug, 23	1.80 L.	2.03 L.	+12.8%	+8.3%
5Y	09 Aug, 21	3 L.	3.67 L.	+22.2%	+8.1%
SI	09 Jul, 18	4.85 L.	7.56 L.	+55.9%	+10.9%

Lumpsum Returns

Amount (₹)

Period	Inv Date	Inv(₹)	Val(₹)	Abs(%)	CAGR
1Y	16 Jul, 25	1 L.	1.04 L.	+4.0%	+4.0%
2Y	16 Jul, 24	1 L.	1.10 L.	+10.0%	+4.9%
3Y	17 Jul, 23	1 L.	1.46 L.	+45.8%	+13.4%
5Y	16 Jul, 21	1 L.	1.14 L.	+13.8%	+2.6%
SI	03 Jul, 18	1 L.	2.62 L.	+162.4%	+12.8%

SIP Planner

Visualize how small monthly investments grow over time.

Monthly SIP Amount

HNI/UHNI? Enter manually (Max: ₹10 Cr)

₹

Investment Tenure

Max: 40 Years

Years

Expected Annual Return (SIP)

Max: 30%

Expected Inflation

Max: 20%

Annual Step-up

Beat inflation and compound wealth faster with an annual step-up.

Max: 500%

Initial Lumpsum

HNI/UHNI? Enter manually (Max: ₹1000 Cr)

₹

Expected Return on Lumpsum

Max: 30%

Future Value

₹23.80L

With SIP Amount ₹5,000

Total Invested

₹9.00L

Total Gained

₹14.80L

SIP Invested₹9.00L

SIP Gain₹14.80L

Lumpsum Inv.₹0

Lumpsum Gain₹0

Reality Check: Your future value will be today's ₹8.62L at inflation rate 7%

Tip: You can set a Goal first in the Goal Planner to calculate SIP targets adjusted for inflation.